← Назад к работе
Работы, цитирующие эту работу
Работ: 5
Работа: Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia
Продукты
Для разработчиков
AkademBaseОткрытый API экосистемыРабот: 5
Работа: Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia